4//SEC Filing
BEDU-ADDO FRANK 4
Accession 0001140361-25-027405
CIK 0001472091other
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 6:12 PM ET
Size
7.7 KB
Accession
0001140361-25-027405
Insider Transaction Report
Form 4
BEDU-ADDO FRANK
DirectorPresident/CEO
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-06-12+150,000→ 150,000 totalExercise: $1.79Exp: 2035-06-12→ Common Stock (150,000 underlying) - Award
Employee Stock Option (Right to Buy)
2024-02-28+300,000→ 300,000 totalExercise: $5.87Exp: 2034-02-28→ Common Stock (300,000 underlying)
Footnotes (2)
- [F1]The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on February 28,2025, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
- [F2]The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on June 12, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Documents
Issuer
PDS Biotechnology Corp
CIK 0001472091
Entity typeother
Related Parties
1- filerCIK 0001770756
Filing Metadata
- Form type
- 4
- Filed
- Jul 24, 8:00 PM ET
- Accepted
- Jul 25, 6:12 PM ET
- Size
- 7.7 KB